HomeProductsBioactive CompoundsTransporters & Ion ChannelsP-GpTariquidar
Chemical structure of CAS 206873-63-4

Tariquidar

In Stock•Starting at $81 for 5 mg•Purity ≥ 98%
CAS No.206873-63-4
MDL No.MFCD09837824
MFC38H38N4O6
MW646.70
InChI KeyLGGHDPFKSSRQNS-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$81In Stock
10 mg98%$84In Stock
25 mg98%$201In Stock
50 mg98%$266In Stock
100 mg98%$471In Stock
250 mg98%$1173In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Tariquidar is a benzamide.

CAS No.206873-63-4
Product NameTariquidar

Biological Targets

ABCB1

Associated Conditions

adrenal cortex carcinoma·ovarian cancer·breast cancer·lung cancer·neuropathic pain·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

P-Glycoprotein on Blood-Brain Barrier Plays a Vital Role in Fentanyl Brain Exposure and Respiratory Toxicity in Rats.

Toxicological sciences : an official journal of the Society of Toxicology • Vol. 164, Issue 1 • 2018
PMID: 29669042DOI: 10.1093/toxsci/kfy093

Increasing nerve agent treatment efficacy by P-glycoprotein inhibition.

Chemico-biological interactions • Vol. 259, Issue Pt B • 2016
PMID: 27287416DOI: 10.1016/j.cbi.2016.06.012

Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice.

Scientific reports • Vol. 5 • 2015
PMID: 26134275PMC: PMC4488747DOI: 10.1038/srep11747

Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.

Journal of medicinal chemistry • Vol. 54, Issue 16 • 2011
PMID: 21721528PMC: PMC3201829DOI: 10.1021/jm2006047

Documentation

Similar Products